News & Highlights
08.24.2026 LifeActive Bio Announces Appointment of Lori Brown to the Board of Directors
Lori Brown, Chief Operating Officer of LifeActive Bio has joined LifeActive Bio’s Board of Directors.
08.14.2026 LifeActive Bio Appoints Dr. John L. Jefferies to the Board of Directors
Dr. John Jefferies, an internationally recognized cardiologist, researcher and innovator has joined LifeActive Bio’s Board of Directors.
04.30.2026 XnanodeX™ Nano-Emulsion Technology Partners with cGMP Manufacturer
LifeActive Bio announces a new partnership with a contract manufacturer in Dallas, TX.
04.27.2026 LifeActive Bio Launches XnanodeX™ Clean Label Base for Cosmetic & Beauty Products
LifeActive Bio unveils XnanodeX™ Clean Label Base, a patent-protected Lipo-Nano-emulsion platform for cosmetic brands building under-10-ingredient SKUs in days.
04.02.2026 – Commercial Launch and Chief Medical Officer Appointment
LifeActive Bio Enters Revenue Stage with Four Product Lines and Landmark Clinical Appointment
01.09.2025 – Introducing LifeActive Bio
LifeActive Bio Emerges from Stealth Mode with Innovative Platform to Enhance Therapeutic Delivery and Absorption
©Copyright 2026. LifeActive, Inc. DBA LifeActive Bio. All Rights Reserved.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.